The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.

Current cancer drug targets

Volumn 10, Issue 8, 2010, Pages 849-857

  Grusch, Michael ^a   Petz, Michaela ^b   Metzner, Thomas ^b   Oztürk, Deniz ^b   Schneller, Doris ^b   Mikulits, Wolfgang ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CLINICAL TRIAL (TOPIC); DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79961211320     PISSN: None     EISSN: 18735576     Source Type: Journal    
DOI: None     Document Type: Review

References (0)